MAFA and Hyperglycemia: Administration of the insulin receptor antagonist S961 imparts hyperinsulinism and marked hyperglycemia in male mice (Figure 2A) (24–26) with a concomitant reduction of islet β cell MafA protein and mRNA levels (Figure 2B and data not shown).